From the Makers of
PATANOL® solution
&
PATANASE®
Nasal Spray

FIRST-TIME
REFILL
Rate Your Symptoms
How serious are your allergies?
Find out with this
simple tool.
Learn more

Site Map

Daily Allergy Medication
Please choose a site selection from the site map below, the left navigation bar, or restart at the home page.

Allergy Season

  • Allergy 101
  • Allergy Medication

Airborne Allergens

  • Seasonal Allergies
  • Outdoor Allergies
  • Indoor Allergies
  • Why am I an Allergy Sufferer?

Allergic Conjunctivitis

  • Allergy Eye Symptoms
  • Allergy Eye Causes
  • Allergy Eye Treatments
  • Kids & Allergy Eyes

About PATADAY™ solution

  • Prescribing Information

Ask Your Doctor

  • Rate Your Symptoms
  • Find a Doctor
  • Ocular Allergies

About PATANOL® solution

Faqs

Tell-A-Friend

Contact Us

 
  • Home
  • Allergy Season
    • Allergy 101
  • Airborne Allergens
    • Seasonal Allergies
    • Outdoor Allergies
    • Indoor Allergies
  • Allergic Conjunctivitis
    • Allergy Eye Symptoms
    • Allergy Eye Causes
    • Allergy Eye Treatments
    • Kids & Allergy Eyes
  • About PATADAY™ solution
    • Prescribing Information
  • Ask Your Doctor
    • Rate Your Symptoms
    • Find a Doctor
  • FAQs
Increase Text Size: A | A | A
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

IMPORTANT SAFETY INFORMATION: PATADAY™ solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis. PATADAY™ solution is contraindicated in patients with a hypersensitivity to any components of this product. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least ten minutes after instilling PATADAY™ solution before they insert their contact lenses. Safety and effectiveness in pediatric patients below the age of 3 has not been established. The most common adverse reactions to PATADAY™ solution were cold syndrome and pharyngitis reported at an incidence of approximately 10%. Other adverse events included eye pain, blurred vision, sinusitis and headache occurring in 5% or less of the patients. The recommended dose is one drop in each affected eye once-a-day.
Click here for more information.
Alcon ®
Tell-A-FriendContact UsPATANOL® SolutionSite Map
Copyright © 2010 Alcon, Inc., a global company based in Hünenberg, Switzerland. Not all products are approved in every market and approved labeling and instructions may vary by local country. See Privacy Policy and Terms & Conditions for use of this site.
Other Alcon sites:  Patanase.com   Dry eye   ICAPSVitamins.com   Opti-Free.com   TravatanZ.com   Ciprodex.com   AcrySofReSTOR.com